| March | 03 | Çѹ̾àǰ-GSK, º¹ÇÕ½Å¾à °øµ¿°³¹ß·ÆÇ¸Å °è¾à |
| March | 03 | È÷¾Ë·ç·Ð»ê+µ¦½ºÆÇÅ×³î ¼ººÐ 'ÄھسªÀß½ºÇÁ·¹ÀÌ' Ãâ½Ã |
| March | 03 | ÇѹÌȦµù½º, Çѹ̻çÀ̾𽺷Π»ç¸í º¯°æ |
| March | 03 | ºñ¸¸¼º ´ç´¢Ä¡·á½Å¾à(HM47000), ¹üºÎó ÀüÁֱ⠽žà°úÁ¦ ¼±Á¤ |
| February | 02 | Á¦11ȸ Çѹ̼öÇʹ®Çлó ½Ã»ó½Ä(´ë»ó : ¾î¸Ó´Ï¿Í ¾Æµé/±èöȯ) |
| February | 02 | º¹ºÎºñ¸¸ Ä¡·á õ¿¬¹°½Å¾à(ALS-L1023) µµÀÔ |
| February | 02 | ¾Æ¸ðÀßź, ±¹Á¦ ÇмúÁö¿¡ ¿¬¼Ó µîÀç(BMC, AJCD, Clinical Therapeutics) |
| January | 01 | LAPS-GCSF, Ú¸ ½ºÆåÆ®·³Þä¿Í °øµ¿°³¹ß ¹× »ó¾÷È °è¾à |
| January | 01 | ¸ù°ñ MEICÞä¿Í ÀϹݾà 13ǰ¸ñ ¼öÃâ°è¾à |
| January | 01 | Çѹ̾àǰ, °í¿ë³ëµ¿ºÎ ¼±Á¤ °í¿ëâÃâ ¿ì¼ö±â¾÷ |